Sale!

CACNA1S Gene Malignant hyperthermia type 5 Genetic Test

4,400 د.إ

-21%

The CACNA1S gene is associated with a condition known as malignant hyperthermia type 5, a rare but severe reaction to certain anesthesia drugs, leading to a rapid increase in heart rate and body temperature, muscle rigidity, and other symptoms. This condition is genetic, meaning it is passed down through families.

To diagnose this condition and identify individuals at risk, a genetic test targeting the CACNA1S gene can be conducted. This test is crucial for people with a family history of malignant hyperthermia or those who have experienced symptoms of the condition during surgery. Early identification can help manage the risk and prepare safer anesthesia protocols for affected individuals.

In the United Arab Emirates, this specific genetic test is available at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the CACNA1S gene test for malignant hyperthermia type 5 at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals and healthcare providers to manage and mitigate the risks associated with malignant hyperthermia, ensuring safer surgical outcomes for those with the genetic predisposition.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

CACNA1S Gene Malignant Hyperthermia Type 5 Genetic Test

Test Name: CACNA1S Gene Malignant Hyperthermia Type 5 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CACNA1S Gene Malignant Hyperthermia Type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1S Gene Malignant Hyperthermia Type 5.

Test Details

The CACNA1S gene is associated with a condition called malignant hyperthermia type 5. Malignant hyperthermia is a rare, life-threatening reaction to certain medications used during general anesthesia. It is characterized by a rapid increase in body temperature, muscle rigidity, and other symptoms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously. In the case of malignant hyperthermia type 5, NGS genetic testing can be used to identify mutations or variations in the CACNA1S gene that may be associated with the condition.

By analyzing the individual’s DNA, NGS genetic testing can provide information about the presence or absence of specific genetic variations that may increase the risk of developing malignant hyperthermia. This information can be used to diagnose the condition, assess the risk of an adverse reaction to anesthesia, and guide treatment decisions.

It is important to note that NGS genetic testing for malignant hyperthermia type 5 is typically performed in individuals with a suspected or confirmed diagnosis of malignant hyperthermia or a family history of the condition. The test is usually ordered by a healthcare provider who specializes in genetics or anesthesiology.

Test Name CACNA1S Gene Malignant hyperthermia type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CACNA1S Gene Malignant hyperthermia type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1S Gene Malignant hyperthermia type 5
Test Details

The CACNA1S gene is associated with a condition called malignant hyperthermia type 5. Malignant hyperthermia is a rare, life-threatening reaction to certain medications used during general anesthesia. It is characterized by a rapid increase in body temperature, muscle rigidity, and other symptoms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously. In the case of malignant hyperthermia type 5, NGS genetic testing can be used to identify mutations or variations in the CACNA1S gene that may be associated with the condition.

By analyzing the individual’s DNA, NGS genetic testing can provide information about the presence or absence of specific genetic variations that may increase the risk of developing malignant hyperthermia. This information can be used to diagnose the condition, assess the risk of an adverse reaction to anesthesia, and guide treatment decisions.

It is important to note that NGS genetic testing for malignant hyperthermia type 5 is typically performed in individuals with a suspected or confirmed diagnosis of malignant hyperthermia or a family history of the condition. The test is usually ordered by a healthcare provider who specializes in genetics or anesthesiology.